東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Tumor angiogenesis = a key target fo...

Marme, Dieter.

Linked to FindBook

Google Book

Amazon

博客來

Tumor angiogenesis = a key target for cancer therapy /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Tumor angiogenesis/ edited by Dieter Marme.
Reminder of title:	a key target for cancer therapy /
other author:	Marme, Dieter.
Published:	Cham :Springer International Publishing : : 2019.,
Description:	xxii, 681 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eReference
Subject:	Tumors - Growth. -
Online resource:	https://doi.org/10.1007/978-3-319-33673-2
ISBN:	9783319336732

Tumor angiogenesis = a key target for cancer therapy /
Tumor angiogenesisa key target for cancer therapy /[electronic resource] :edited by Dieter Marme. - Cham :Springer International Publishing :2019. - xxii, 681 p. :ill., digital ;24 cm.

This exhaustive work shows that new therapies using anti-angiogenic drugs are of particular importance because they can be used against many different types of cancer, as tumor angiogenesis seems to be involved in most if not all solid metastasizing malignancies. The first part of this book summarizes the knowledge acquired on the molecular entities that play a role in tumor angiogenesis and their mechanisms of action. Furthermore, the identification of molecular markers and their validation as predictive and/or prognostic tools is reviewed. In the second and most important part, the clinical applications of anti-angiogenic treatments are documented for a wide variety of tumors. In particular, the modes of combination with other targeted and/or cytotoxic cancer therapies are presented.

ISBN: 9783319336732

Standard No.: 10.1007/978-3-319-33673-2doiSubjects--Topical Terms:

895425
Tumors
--Growth.

LC Class. No.: RC256 / .T866 2019

Dewey Class. No.: 616.994

Tumor angiogenesis = a key target for cancer therapy /
LDR:01859nmm a2200325 a 4500 001 2242613
003 DE-He213
005 20200902113643.0
006 m d
007 cr nn 008maaau
008 211207s2019 sz s 0 eng d
020 $a 9783319336732 $q (electronic bk.)
020 $a 9783319336718 $q (paper)
024 7 $a 10.1007/978-3-319-33673-2 $2 doi
035 $a 978-3-319-33673-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RC256 $b .T866 2019
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.994 $2 23
090 $a RC256 $b .T925 2019
245 0 0 $a Tumor angiogenesis $h [electronic resource] : $b a key target for cancer therapy / $c edited by Dieter Marme.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a xxii, 681 p. : $b ill., digital ; $c 24 cm.
520 $a This exhaustive work shows that new therapies using anti-angiogenic drugs are of particular importance because they can be used against many different types of cancer, as tumor angiogenesis seems to be involved in most if not all solid metastasizing malignancies. The first part of this book summarizes the knowledge acquired on the molecular entities that play a role in tumor angiogenesis and their mechanisms of action. Furthermore, the identification of molecular markers and their validation as predictive and/or prognostic tools is reviewed. In the second and most important part, the clinical applications of anti-angiogenic treatments are documented for a wide variety of tumors. In particular, the modes of combination with other targeted and/or cytotoxic cancer therapies are presented.
650 0 $a Tumors $x Growth. $3 895425
650 0 $a Cancer $x Treatment. $3 618125
650 0 $a Oncology. $3 751006
650 0 $a Medicine. $3 641104
650 0 $a Toxicology. $3 556884
650 1 4 $a Cancer Research. $3 891172
650 2 4 $a Molecular Medicine. $3 890952
650 2 4 $a Pharmacology/Toxicology. $3 890953
700 1 $a Marme, Dieter. $3 899882
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eReference
856 4 0 $u https://doi.org/10.1007/978-3-319-33673-2
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Reference Module Biomedical and Life Sciences (SpringerNature-43744)